S Oliva
Overview
Explore the profile of S Oliva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scarano A, Murmura G, Lorusso F, DI Carlo T, Oliva S
J Prev Med Hyg
. 2020 Aug;
61(2):E296-E298.
PMID: 32803014
Introduction: The microbiological safety and control of the water used in dental practice has a critical importance for avoiding cross-linked infections in the dental office. The aim of this study...
2.
Battella S, Oliva S, Franchitti L, La Scaleia R, Soriani A, Isoldi S, et al.
Mucosal Immunol
. 2019 Oct;
12(6):1358-1369.
PMID: 31582819
De-regulated T-cell activation and functions are pivotal in the orchestration of immune-mediated tissue damage in IBD. We investigated the role of DNAM-1 (co-activating)/TIGIT (co-inhibitory)/ligand axis in the regulation of T-cell...
3.
Gay F, Oliva S, Petrucci M, Montefusco V, Conticello C, Musto P, et al.
Leukemia
. 2016 Dec;
31(8):1727-1734.
PMID: 28008174
In newly diagnosed myeloma patients, upfront autologous transplant (ASCT) prolongs progression-free survival 1 (PFS1) compared with chemotherapy plus lenalidomide (CC+R). Salvage ASCT at first relapse may still effectively rescue patients...
4.
Larocca A, Bringhen S, Petrucci M, Oliva S, Falcone A, Caravita T, et al.
Leukemia
. 2016 Feb;
30(6):1320-6.
PMID: 26898189
This phase 2 trial evaluated three low-dose intensity subcutaneous bortezomib-based treatments in patients ⩾75 years with newly diagnosed multiple myeloma (MM). Patients received subcutaneous bortezomib plus oral prednisone (VP, N=51)...
5.
Ferrero S, Ladetto M, Drandi D, Cavallo F, Genuardi E, Urbano M, et al.
Leukemia
. 2014 Jul;
29(3):689-95.
PMID: 25027515
Polymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis is a useful prognostic tool in multiple myeloma (MM), although its long-term impact still needs to be addressed. This report presents...
6.
Di Nardo G, Barbara G, Cucchiara S, Cremon C, Shulman R, Isoldi S, et al.
Neurogastroenterol Motil
. 2013 Dec;
26(2):196-204.
PMID: 24304324
Background: Neuroimmune interactions and inflammation have been proposed as factors involved in sensory-motor dysfunction and symptom generation in adult irritable bowel syndrome (IBS) patients. In children with IBS and healthy...
7.
Teixeira J, Garruco A, Oliva S
Eur J Orthop Surg Traumatol
. 2013 Nov;
6(2):79-82.
PMID: 24193668
The authors have reviewed 75 cases of infected Pseudarthrosis treated over the last five years (1989-1993) in the Septic Osteo Articular Pathology Unit (UP.S.O.A.) in the Orthopaedic Service of the...
8.
Falco P, Cavallo F, Larocca A, Rossi D, Guglielmelli T, Rocci A, et al.
Leukemia
. 2012 Sep;
27(3):695-701.
PMID: 22996335
This multicenter phase II trial evaluated the safety and efficacy of lenalidomide-prednisone (RP) induction, followed by lenalidomide-melphalan-prednisone (MPR) consolidation and RP maintenance in elderly unfit newly diagnosed myeloma patients. Patients...
9.
La Scaleia R, Barba M, Di Nardo G, Bonamico M, Oliva S, Nenna R, et al.
Mucosal Immunol
. 2012 May;
5(5):513-23.
PMID: 22569303
Mucosal interleukin (IL)-17A-producing T cells contribute to protective antimicrobial responses and to epithelial barrier integrity; their role in celiac disease (CD) is debated. We analyzed the frequency and developmental dynamics...
10.
Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, et al.
Aliment Pharmacol Ther
. 2011 Dec;
35(3):327-34.
PMID: 22150569
Background: Intestinal microbiota manipulation, one of the pathogenetic components of inflammatory bowel disease (IBD), has become an attractive therapy for ulcerative colitis (UC). Aim: To assess in children with active...